ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

ABSTRACT Background: The treatment of advanced gastric cancer with curative intent is essentially surgical and chemoradiotherapy is indicated as neo or adjuvant to control the disease and prolong survival. Aim: To assess the survival of patients undergoing subtotal or total gastrectomy with D2 lym...

Full description

Bibliographic Details
Main Authors: Nelson Adami ANDREOLLO, Eric DRIZLIONOKS, Valdir TERCIOTI-JUNIOR, João de Souza COELHO-NETO, José Antonio Possato FERRER, José Barreto Campello CARVALHEIRA, Luiz Roberto LOPES
Format: Article
Language:English
Published: Colégio Brasileiro de Cirurgia Digestiva 2019-12-01
Series:ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Subjects:
Gastric neoplasm
Adjuvant therapy
Gastrectomy
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000400303&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000400303&tlng=en

Similar Items